Drugs / Fluvirin®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01885117 | Aug → Sep 2013 | influenza | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluvirin | “A Phase III, Open Label, Single Arm, Multi Center Study to Evaluate Safety and Immunogenicity of a Trivalent, Surface Antigen Inactivated Subunit Influenza Virus (Fluvirin®) in...” NCT01885117 ↗ |
| Known as | TIVf | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01885117 ↗ |
| Modality | Vaccine | “trivalent, surface antigen, inactivated influenza vaccine” NCT01885117 ↗ |